LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹8.52 Cr | ₹6.59 Cr | ₹3.32 Cr | ₹3.16 Cr | ₹0.53 Cr |
What is the latest Contingent Liabilities ratio of LACTOSE (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹8.52 Cr |
Mar2023 | ₹6.59 Cr |
Mar2022 | ₹3.32 Cr |
Mar2021 | ₹3.16 Cr |
Mar2020 | ₹0.53 Cr |
How is Contingent Liabilities of LACTOSE (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹8.52 Cr | 29.32 | |
Mar2023 | ₹6.59 Cr | 98.58 | |
Mar2022 | ₹3.32 Cr | 4.93 | |
Mar2021 | ₹3.16 Cr | 501.14 | |
Mar2020 | ₹0.53 Cr | - |
Compare Contingent Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹123.9 Cr | 4.7% | 0.6% | -30.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 4.7% |
0.6% |
-30.7% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses